Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Cost of Revenue: 2009-2025

Historic Cost of Revenue for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $98.4 million.

  • BIO-TECHNE's Cost of Revenue fell 7.51% to $98.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $421.4 million, marking a year-over-year increase of 4.29%. This contributed to the annual value of $429.4 million for FY2025, which is 10.28% up from last year.
  • According to the latest figures from Q3 2025, BIO-TECHNE's Cost of Revenue is $98.4 million, which was down 16.68% from $118.2 million recorded in Q2 2025.
  • BIO-TECHNE's Cost of Revenue's 5-year high stood at $118.2 million during Q2 2025, with a 5-year trough of $75.3 million in Q1 2021.
  • Its 3-year average for Cost of Revenue is $100.5 million, with a median of $98.8 million in 2024.
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 32.89% in 2021, then decreased by 7.51% in 2025.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Cost of Revenue stood at $85.6 million in 2021, then increased by 3.08% to $88.2 million in 2022, then grew by 8.83% to $96.0 million in 2023, then grew by 7.43% to $103.1 million in 2024, then declined by 7.51% to $98.4 million in 2025.
  • Its Cost of Revenue stands at $98.4 million for Q3 2025, versus $118.2 million for Q2 2025 and $101.6 million for Q1 2025.